The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Thirty-two strains of Bordetella bronchiseptica were tested for their antimicrobial susceptibilities to nine fluoroquinolones. The most active agents were fleroxacin, temafloxacin, ciprofloxacin (MIC 90 1 μg/ml), ofloxacin, lomefloxacin and enoxacin (MIC 90 2 μg/ml). Pefloxacin and norfloxacin were active only against 59.3 and 83.1%, respectively, of the strains tested, whereas rufloxacin lacked activity against all the strains of B. bronchiseptica tested.
Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Policlinico Universitario, Torre Biologica, 2o piano, Universitá di Messina, 98100 Messina, Italy
Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Policlinico Universitario, Torre Biologica, 2o piano, Universitá di Messina, 98100 Messina, Italy